Expected Survival ≥3 Months
1 clinical trials · Condition
◉ Watch Expected Survival ≥3 Months
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer (NCT06554535) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2024-10-01 |
Track Expected Survival ≥3 Months automatically
Every clearance here is in the API, with alerts when new ones post.